Drug or treatment
Mepolizumab clinical trials
As of November 12, 2026, Find a Trial lists 5 clinical trials of Mepolizumab that are recruiting, at sites in 5 countries (most in Spain (1), Greece (1), Netherlands (1)). By phase: Phase 4 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 5Countries
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Mepolizumab with or without in-office nasal polypectomy for chronic rhinosinusitis with nasal polyps | Phase 4 | Barakaldo and 6 other locations | Recruiting | Sep 11, 2026 |
| Stopping mepolizumab or dupilumab to see if nasal polyps stay in complete remission. | Phase 4 | Copenhagen, Region H and 5 other locations | Recruiting | Dec 5, 2025 |
| Investigating the Role of Nasal Microbiome in Eosinophilic Granulomatosis with Polyangiitis | — | Groningen | Recruiting | Mar 7, 2024 |
| Identifying biomarkers for response to mepolizumab in patients with nasal polyps and asthma | — | Thessaloniki, Exochi and 1 other locations | Recruiting | Feb 1, 2023 |
| Understanding asthma flare-ups in patients treated with mepolizumab | — | Québec, Quebec | Recruiting | Oct 8, 2020 |
All recruiting trials (5)
-
Mepolizumab with or without in-office nasal polypectomy for chronic rhinosinusitis with nasal polyps
This study tests whether adding mepolizumab, alone or with in-office nasal polypectomy, helps adults with chronic rhinosinusitis with nasal polyps who need biologic treatment.
-
Stopping mepolizumab or dupilumab to see if nasal polyps stay in complete remission.
This trial will test whether adults with well-controlled nasal polyps who have been on mepolizumab or dupilumab can safely stop the biologic and remain symptom-free.
-
Investigating the Role of Nasal Microbiome in Eosinophilic Granulomatosis with Polyangiitis
This study is trying to see how the bacteria in the nose affect the immune system in people with Eosinophilic Granulomatosis with Polyangiitis and related conditions, and whether a new treatment can change that.
-
Identifying biomarkers for response to mepolizumab in patients with nasal polyps and asthma
This study is testing if mepolizumab can help people with nasal polyps and asthma feel better, while also looking for signs that show who will benefit from the treatment.
-
Understanding asthma flare-ups in patients treated with mepolizumab
This study looks at how asthma flare-ups happen in people taking mepolizumab over two years to better understand their symptoms and inflammation.
Quick answers
How many clinical trials of Mepolizumab are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 5 countries. The most sites are in Spain (1 trial), Greece (1 trial), Netherlands (1 trial), Canada (1 trial), Denmark (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 4: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.